Indivior Pharmaceuticals Inc (INDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 89,000 | 210,000 | 108,000 | 65,000 | 47,000 |
| Depreciation Amortization | 4,000 | 20,000 | 15,000 | 10,000 | 5,000 |
| Income taxes - deferred | 27,000 | -46,000 | -8,000 | 7,000 | -2,000 |
| Accounts receivable | -20,000 | 3,000 | -3,000 | 15,000 | 11,000 |
| Other Working Capital | -163,000 | -257,000 | 42,000 | 139,000 | 17,000 |
| Other Operating Activity | 54,000 | 43,000 | 40,000 | -3,000 | -3,000 |
| Operating Cash Flow | $-9,000 | $-27,000 | $194,000 | $233,000 | $75,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -5,000 | -20,000 | -14,000 | -11,000 | -5,000 |
| PPE Investments | -20,000 | -66,000 | -42,000 | -22,000 | -5,000 |
| Sale Of Investment | 6,000 | 20,000 | 14,000 | 11,000 | 6,000 |
| Purchase Sale Intangibles | N/A | -1,000 | -1,000 | -1,000 | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | -1,000 |
| Investing Cash Flow | $-19,000 | $-66,000 | $-42,000 | $-22,000 | $-5,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 489,000 | N/A | N/A | N/A | N/A |
| Debt Repayment | -333,000 | -17,000 | -12,000 | -8,000 | -4,000 |
| Common Stock Issued | N/A | 2,000 | 2,000 | 1,000 | 1,000 |
| Common Stock Repurchased | -126,000 | -11,000 | -11,000 | -11,000 | -11,000 |
| Other Financing Activity | -23,000 | -4,000 | -4,000 | -4,000 | -3,000 |
| Financing Cash Flow | $7,000 | $-30,000 | $-25,000 | $-22,000 | $-17,000 |
| Exchange Rate Effect | N/A | -1,000 | -1,000 | 1,000 | N/A |
| Beginning Cash Position | 195,000 | 319,000 | 319,000 | 319,000 | 319,000 |
| End Cash Position | 175,000 | 195,000 | 445,000 | 510,000 | 372,000 |
| Net Cash Flow | $-20,000 | $-124,000 | $126,000 | $191,000 | $53,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,000 | -27,000 | 194,000 | 233,000 | 75,000 |
| Capital Expenditure | -20,000 | -66,000 | -42,000 | -22,000 | -5,000 |
| Free Cash Flow | -29,000 | -93,000 | 152,000 | 211,000 | 70,000 |